Latest FDA Stories
New Label Supports Individualized Therapy Through Greater Dosing Flexibility From Daily to Once Every Two Weeks (Biweekly); Underscores CSL Behring's Commitment to Improving Patients' Lives
Unveils FastForward Bunion Correction System ATLANTA, Feb.
Patient Enrollment to begin Q2 of 2015 SAN DIEGO, Feb. 2, 2015 /PRNewswire/ -- Leading BioSciences, Inc.
Only prescription medication in U.S. to combine the dual mechanisms of action of SGLT2 and DPP-4 inhibitors to improve glycemic control as an adjunct to diet and exercise RIDGEFIELD, Conn.
MicroPulse® Technology Offers Minimally Invasive, Repeatable Treatment Option that Can Slow Progression of Disease; Delay Surgical Intervention MOUNTAIN VIEW, Calif., Feb.
The Firm is representing men who allegedly suffered serious cardiovascular events due to their use of prescription testosterone treatments. New York, New York
LEXINGTON, Mass., Jan. 30, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that the U.S.
Investor interest in the regulation of nanomaterials and nanotechnology applications has led to the US EPA and FDA, as well as the European Union addressing nanomaterials and nanotechnology applications
The FDA continues to struggle to catch up on ANDA approvals with an average approval time of three years.
The Firm is representing numerous plaintiffs who have filed similar Risperdal gynecomastia claims in the mass tort proceeding underway in Pennsylvania. New York,
- One who brings meat to the table; hence, in some countries, the official title of the grand master or steward of the king's or a nobleman's household.